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Abstract
Introduction: Peri-implantitis is a late complication of dental implant treatment, induced by microbiological 
changes. Since the disorder is frequent, a review is indicated of the microorganisms that influence it and of the 
existing treatment options.
Objective: To conduct a literature review of the microbiota associated to peri-implantitis and the existing treat-
ment options.
Material and Method: A PubMed literature search was made of the studies on the microbiota associated to dental 
implants in healthy patients and patients with peri-implantitis, as well as of the latest treatment developments, 
using the following key words: “peri-implantitis AND microbiota”, “periimplantitis AND microbiota”, “peri-
implantitis AND treatment”, and “periimplantitis AND treatment”. Only clinical studies in humans were consid-
ered. The following criteria were applied for including articles in the analysis: a) for the peri-implant microbiota, 
the search limits were human studies after the year 2000; and b) for the treatment of peri-implantitis, the search 
limits were randomized and controlled clinical trials (RCTs) in humans, with a minimum follow-up of 4 months, 
and publication after the year 2000.
Results: A total of 18 articles were selected in relation to peri-implant microbiota, and 13 in relation to the treat-
ment of peri-implantitis (8 involving nonsurgical mechanical treatments and 5 surgical procedures).
Conclusions: Evaluation of the literature has shown the microbiota associated to peri-implantitis to be more com-
plex than that found under healthy peri-implant conditions – the main flora consisting of anaerobic gramnegative 
bacteria. No clear criteria have been identified for the diagnosis and treatment of peri-implantitis.
Key words: Peri-implant microbiota, dental implants, dental biofilm, peri-implantitis treatment, oral microbiol-
ogy, peri-implant disease, peri-implant infection.
Ata-Ali J, Candel-Marti ME, Flichy-Fernández AJ, Peñarrocha-Oltra D, 
Balaguer-Martinez JF, Peñarrocha MA. Peri-implantitis: Associated mi-
crobiota and treatment. Med Oral Patol Oral Cir Bucal. 2011 Nov 1;16 
(7):e937-43.   
 http://www.medicinaoral.com/medoralfree01/v16i7/medoralv16i7p937.pdf
Article Number: 17227          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
doi:10.4317/medoral.17227
http://dx.doi.org/doi:10.4317/medoral.17227
Med Oral Patol Oral Cir Bucal. 2011 Nov 1;16 (7):e937-43.                                                                                                                                               Microbiota and treatment of peri-implantitis
e938
Introduction
While dental implant treatment offers a high success 
rate, it is not without complications (1,2). The complica-
tions associated with implant placement can be classi-
fied on a chronological basis: a) early complications, re-
sulting from surgical trauma, inadequate bone volume, 
a lack of primary stability, intrabony infection or bacte-
rial contamination of the receptor zone; and b) late com-
plications, related to microbiological (peri-implantitis) 
and biomechanical changes (occlusal overload) (3).
The Sixth European Workshop in Periodontics held in 
2008 defined peri-implant diseases as follows: peri-im-
plant mucositis is the presence of inflammation of the 
peri-implant mucosa without signs of loss of bone sup-
port, while peri-implantitis, in addition to inflammation 
of the mucosa, is characterized by a loss of bone support 
(4,5).
Mucositis appears in 80% of the patients and in 50% of 
the implants, while peri-implantitis is observed in 28-
56% of the patients, and in 12-43% of the implants (5). 
Regarding the diagnosis of peri-implantitis, probing of 
the peri-implant sulcus is an essential element for the 
diagnosis of peri-implant infections, in the same way as 
in periodontitis. It is important to perform probing with 
gentle pressure (preferably 0.2-0.3 N). Other important 
signs are bleeding in response to probing, the presence 
of pus, and radiologically confirmed loss of bone sup-
port – the latter being the clinical sign confirming the 
presence of peri-implantitis (6).
In 1992, Socransky and Haffajee (7) modified the postu-
lates of Koch establishing the criteria that identify peri-
odontal pathogens. The study of the biofilm using DNA 
hybridization techniques made it possible to group spe-
cific bacterial species and relate them to clinical health 
or disease. While the “purple” (with fundamentally aer-
obic flora lacking mobility), “yellow” and “green” com-
plexes are not associated to disease, the “orange” (F. 
nucleatum/periodontoliticum, P. intermedia, P. micros) 
and “red” complexes (P. gingivalis, T. forsythia, T. den-
ticola) cause disease in the presence of virulent clones 
with adequate intra- and extra-chromosomal genetic 
information, and when found in sufficient numbers to 
overcome the host immune resistance. A. actinomyce-
temcomitans is also regarded as being periodontopatho-
genic, although it is not included in any group.
A PubMed literature search was made of the studies on 
the microbiota associated to dental implants in healthy 
patients and patients with peri-implantitis, as well as of 
the latest treatment developments, using the following 
key words: “peri-implantitis AND microbiota”, “peri-
implantitis AND microbiota”, “peri-implantitis AND 
treatment”, and “periimplantitis AND treatment”. Only 
clinical studies in humans were considered. The follow-
ing criteria were applied for including articles in the 
analysis: a) for the peri-implant microbiota, the search 
limits were human studies after the year 2000; and b) 
for the treatment of peri-implantitis, the search limits 
were randomized and controlled clinical trials (RCTs) 
in humans, with a minimum follow-up of 4 months, and 
publication after the year 2000. 
A total of 18 articles were selected in relation to peri-
implant microbiota, and 13 in relation to the treatment 
of peri-implantitis (8 involving nonsurgical mechanical 
treatments and 5 surgical procedures).
Peri-Implant Microbiota
Microbiota associated to healthy peri-implant 
tissues
Following exposure of the surface of the implant to the 
oral cavity, the corresponding biofilm is formed. This 
film produces an interphase between the surface of the 
implant and the initial microorganisms, such as for ex-
ample Streptococcus mitis, Streptococcus sanguis and 
Streptococcus oralis. These bacteria create a series of 
prior conditions for the adhesion of periodontal patho-
gens, being able to induce the development of peri-im-
plantitis (8).
Microbiological studies in healthy peri-implant tissues 
have demonstrated the presence of large proportions of 
coccoid cells, with a low proportion of anaerobic / aero-
bic species, a small number of gramnegative species, 
and a low detection of periodontopathogenic bacteria. 
However, it is also possible to find small concentrations 
of anaerobic gramnegative bacilli in some implants 
(3,6,9).
Microbiota associated to peri-implantitis
The locations with peri-implant infections present a 
microbiota very similar to that found in periodontal dis-
ease, such as the species of the red and orange complex-
es, Prevotella nigrescens, Campylobacter rectus and 
Aggregatibacter actinomycetemcomitans, particularly 
serotype b, as well as Staphylococcus aureus, enteric 
bacilli and Candida albicans (3,6,7,10) (Table 1).
The changes produced in the soft and hard tissues (clini-
cally characterized by an increase in pocket depth and 
bone loss) are associated with significant changes in the 
composition of the subgingival microbiota, including 
(9): an increased total bacterial burden or load, with an 
increase in the proportion of Aggregatibacter actino-
mycetemcomitans, Fusobacterium species, Prevotella 
intermedia and Porphyromonas gingivalis, a decrease 
in the proportion of all cocci, and an important increase 
in the proportion of mobile organisms and spirochetes.
In the study published by Shibli et al. (3) the healthy pa-
tients presented a lower total bacterial load than the peri-
implantitis group at both supragingival level (19x106 vs 
40x106) and at subgingival level (6.6x106 vs 22x106)
(p<0.05). In the study by Hultin et al. (12), the evaluated 
periodontal pathogens Aggregatibacter actinomycetem-
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comitans, Porphyromonas gingivalis, Treponema den-
ticola, Tannerella forsythia and Prevotella intermedia 
were present in both healthy and ill patients; however, 
only in the implants with peri-implantitis were these 5 
bacterial species present at concentrations above 1 x 106. 
Aggregatibacter actinomycetemcomitans was present in 
23.5% of the locations with peri-implantitis. The authors 
concluded that Aggregatibacter actinomycetemcomitans 
and Porphyromonas gingivalis are the predominant path-
ogens implicated in peri-implant destruction.
Certain cases of peri-implantitis are characterized by 
periods of rapid and marked destruction compared with 
periodontitis, and a number of differences are moreover 
observed in terms of the host response – prompt treat-
ment being required once such situations have been di-
agnosed (6).  
Author/Year Bacteria in healthy implants
Bacteria in 
implants
with peri-
implantitis
Diagnosis of peri-
implantitis
History of 
periodontal
disease/Presence 
teeth 
Technique 
Leonhardt et al. 
1999 (11) 
Pg, Pi/Pn, Aa, Ss, 
enterococci, Candida 
spp 
Aa, Se, Pg, 
Pi, kb 
Bone loss 3 
threads. 
Bleeding/pus 
probing 
Yes/Yes Culture 
Hultin et al. 2002 
(12) Fss, Pi, Pn , Ec 
Pg, Pi, Tf, 
Aa, Td 
Bone loss  3 
threads (1.8 mm) -/Yes DNA (12 bacteria) 
Botero et al. 2005 
(10) 
Fs, Pi/Pn, Ec, 
enterococci 
Aa, Tf, Td, 
enterococci , 
Pg, Pi/Pn* 
Pocket depth 4 
mm, Bleeding 
upon probing 
-/Yes Culture 
Persson et al. 2006 
(13) - 
Aa, Pg, 
Mm, Pn, Fs, 
Nm 
Bone loss 2 mm. 
Pocket depth 5 
mm with bleeding 
-/- DNA (40 bacteria) 
De Boever et al. 
2006 (14) Aa, Pg, Pi, Tf, Td** - - Yes/Yes DNA probes, PCR 
Salvi et al. 2008 
(15) Tf*, Pm, Lb, Cs, Pi, Sa - - -/Yes DNA (40 bacteria) 
Renvert et al. 2007 
(16) Cs, Fs, Fp, Lb, Nm 
Cs, Lb, Nm, 
Fs, Nm ,Fp 
> 3 threads of 
bone loss, bleeding 
upon probing 
Yes/Yes DNA (40 bacteria) 
Heuer et al. 2007 
(8) Aa, Pg ** - - No/Yes 16S rRNA-PCR 
Shibli et al. 2008 
(3) Vp, Sg, Si, Fp 
Pg, Td, Tf, 
Fs, Pi, Pn, 
An, Si, Sm 
* 
Osteolysis >3 mm 
and inflammatory 
peri-implantitis 
mucosa with 
bleeding and/or 
suppuration 
No/Yes DNA (36 bacteria) 
Emrani et al. 2009 
(17) 
Pg, Pi, Tf, Dp, Cr, Pm, 
Fs, Facultative enteric 
gramnegative cocci 
- - Yes/No Culture 
Persson et al. 2010 
(18) - 
Fs, Sa, Hp, 
Aa, Tf 
Bone loss >2.5 
mm and pocket 
depth  4 mm with 
bleeding/pus upon 
probing 
Yes/Yes DNA (79 bacteria) 
Table 1. Microbiota associated to implants in healthy patients and in subjects with peri-implantitis. Concept of peri-implantitis according 
to different authors.
*< 0.05
** Only these bacteria were evaluated
Aa Aggregatibacter actinomycetemcomitans, Pg Porphyromonas gingivalis, Tf Tannerella forsythia, Pi Prevotella intermedia, Td 
Treponema denticola, Dp Dialister pneumosintes, Cr Campylobacter rectus, Pm Peptostreptococcus micros, Fs Fusobacterium species, 
Cs Capnocytophaga sputigena, Lb Leptotrichia buccalis, Nm Neisseria mucosa, Mm Micromonas micros, Pn Prevotella nigrescens, Ss 
Staphylococcus spp, Sa Staphylococcus aureus, An Actinomyces naeslundii, Si Streptococcus intermedius, Sm Streptococcus mitis, Vp 
Veillonella parvula, Sg Streptococcus gordonii, Fp Fusobacterium periodonticum, Kp Klebsiella pneumoniae, Ec Eikanella corrodens, 
Se Staphylococcus epidermis, Hp Helicobacter pylori
C= Culture 
DNA = Checkerboard DNA-DNA hybridization technique
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Treatment of Peri-Implantitis
Development of the biofilm on the surface of the dental 
implants plays a very important role in the appearance 
of peri-implantitis. The treatments proposed for peri-
implant disease are based on the evidence gained from 
the treatment of periodontitis; however, the surface of 
the implants facilitates adherence of the biofilm bacte-
rial and complicates its elimination (19).
The principal objectives of the treatment of peri-implan-
titis are to reduce bacterial colonization of the surface 
of the implant, mechanically eliminate the bacterial 
microbiota, and introduce an ecology capable of sup-
pressing the subgingival anaerobic flora (9). Both surgi-
cal and nonsurgical techniques have been developed to 
this effect.
Nonsurgical Techniques
In general terms, the treatment of peri-implantitis in the 
case of incipient bone loss involves the elimination of 
plaque and tartar, with chemical plaque control in the 
form of 0.12% chlorhexidine rinses every 8-12 hours 
during 15 days, instructions on oral hygiene, decon-
tamination of the prosthetic abutments, antibiotic treat-
ment, and verification that the design of the prosthesis 
is adequate (20).
In the articles included in our review (Table 2), a total 
of 122 patients were treated, with a follow-up period 
of 4-12 months. The patients selected for nonsurgical 
treatment were those presenting bleeding upon prob-
ing, with a pocket depth of > 4 mm, radiologically con-
firmed bone loss of < 3 mm, exposed implant thread-
ing, absence of mobility, and the presence of anaerobic 
bacteria.
The studies compared ultrasound and carbon fiber cu-
rettes; curettage with or without antibiotics; conven-
tional scaling and the Er:YAG laser (Table 2).
Mechanical treatments
Karring et al. (24) compared the results compared the 
treatment results obtained with the Vector® ultrasound 
system and with carbon fiber curettes. After 6 months 
of follow-up, no significant differences were found 
between the two techniques, and neither proved suf-
ficient to treat peri-implantitis. The same results were 
obtained by Renvert et al. (1) and Persson et al. (18). 
These authors evaluated 31 patients, comparing ultra-
sound (Vector® system) and mechanical treatment with 
curettes. After 6 months, both study groups showed im-
provement in plaque index and bleeding, though with-
out improvement in terms of pocket depth. There were 
no significant differences between the groups, and the 
changes recorded were of no clinical relevance. In rela-
tion to bacterial load, there were no differences in the 
change in bacterial composition in the two groups after 
treatment.
Schwarz et al. (23) compared the Er:YAG laser with me-
chanical treatment plus 0.2% chlorhexidine. The authors 
recorded significant improvements in both groups in the 
clinical parameters studied, though the only significant 
difference between the two groups was related to bleed-
ing upon probing, which was seen to be less pronounced 
in the Er:YAG laser group.
Mechanical treatments associated to antibiotics
The recommended antibiotic treatments are amoxicil-
lin, amoxicillin plus clavulanic acid, amoxicillin plus 
metronidazole, or erythromycin plus tetracycline, with 
a duration of 7-10 days (20).
The selected articles examined treatment with mino-
cycline microspheres, the use of doxycycline, and the 
administration of metronidazole (Table 2). Renvert et 
al. (25), in the year 2006 and in 2008 (19), published 
two articles comparing mechanical debridement plus 
minocycline 1 mg versus mechanical debridement plus 
1 mg of 1% chlorhexidine. The authors concluded that 
the treatments with local antibiotics improved clinical 
parameters such as pocket depth and bleeding, and that 
further studies were needed to establish how often such 
treatment must be repeated. Büchter et al. (22) examined 
the benefits of adding 8.5% doxycycline to mechanical 
scaling – improvements being observed in pocket depth 
and bleeding in the group in which the antibiotic was 
added.
Surgical Techniques
When bone loss is advanced or persists despite the 
initial treatment provided, surgical debridement of the 
peri-implant soft tissues is required, due to the chronic 
infection, with decontamination of the implant surface 
and the application of bone regeneration techniques to 
restore the lost bone (20). The surgical techniques can 
be divided into resection procedures and regenerative 
techniques, depending on the morphology and type of 
bone defect (26) (Table 3).
Resection techniques
Resection techniques are used when there are moder-
ate (< 3 mm) horizontal suprabony defects or vestibular 
dehiscences in a non-aesthetically compromised region. 
These procedures include ostectomy or osteoplasty, 
with the raising of an apical repositioning flap and im-
plantoplasty (20,26).
The objectives of resective surgery are to reduce pocket 
depth and secure adequate soft tissue morphology, in 
order to facilitate adequate hygiene and peri-implant 
health (26).
The resection technique comprises the following steps: 
(31): 1) removal of the supragingival bacterial plaque; 2) 
surgical access; 3) removal of granulation tissue and dis-
intoxication of the surface of the implant; 4) correction 
of bone architecture; 5) modification of implant surface 
roughness; 6) and implantation of plaque control.
As to whether implantoplasty is or is not indicated, 
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Author Diagnosis of peri-implantitis No. I 
Types of 
treatment 
compared 
Follow- up 
(months) Study parameters Conclusions 
Tang et al. 
2002 (21) 
-
27
-gel 25% 
metronidazole 
-ultrasound with 
carbon fiber tips 
12
-plaque
-probing
-bleeding 
-enzyme analysis 
Metronidazole
significantly reduces 
pocket depth; both 
treatments recommended 
Büchter et 
al. 2004 
(22)
-bone loss >50 % 
of implant 
surface and 
pocket depth > 5 
mm 
48
-scaling 
-scaling and 
8.5%
doxycycline 
4
-recession 
-pocket depth 
-bleeding upon 
probing
Antibiotics significantly 
reduce the 3 parameters 
considered 
Schwarz et 
al. 2005 
(23)
-pocket depth > 
6 mm 
-bone loss > 3 
mm
-no mobility 
-no acute 
periodontitis
-presence of 
keratinized
mucosa 
22
-Er:YAG
-mechanical 
treatment plus 
0.2%
chlorhexidine 
digluconate 
6
-plaque
-bleeding 
-probing
-gingival recession 
-attachment loss 
Both treatment improve 
the clinical parameters, 
and laser significantly 
reduces bleeding upon 
probing
Karring et 
al. 2005 
(24)
-Bleeding after 
probing
-pocket >5 mm 
  -1.5 mm 
radiological bone 
loss
-exposed implant 
threads 
-
-Vector® 
-carbon fiber 
curettes 
6
- plaque 
- bleeding 
- probing 
- mesial and distal 
implant bone loss 
No significant differences 
in the results obtained 
with the two treatments 
Renvert et 
al. 2008*, 
2006 (19, 
25)
-pocket depth > 
4 mm 
-bone loss < 3 
threads 
-microbiological
diagnosis
-
-Mechanical 
debridement:
-minocycline 
microspheres
-gel 1% 
chlorhexidine  
12
 -plaque 
-bleeding 
-probing
-microbiological
samples 
Minocycline 
microspheres improve the 
results of treatment 
Renvert et 
al. 2009 
(1)
-pocket depth > 
4 mm 
-bone loss > 2.5 
mm
-
-titanium 
curettes 
-ultrasound 
6
-plaque
-probing
-gingival index 
-bleeding 
Both treatment showed no 
clinically relevant 
changes, with no 
differences between them 
Persson et 
al. 2010 
(18)
-pocket depth > 
4 mm 
-bone loss > 2.5 
mm -
-titanium 
curettes 
-ultrasound 
6 Microbiologicalsamples 
Neither treatment 
significantly reduced 
bacterial load 
Table 2. Nonsurgical treatment of peri-implantitis.
No. I (number of implants)
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Romeo et al. (26) compared resective treatment wither 
alone or in combination with implantoplasty in 17 pa-
tients with 35 implants and a follow-up period of 36 
months. The following clinical parameters were evalu-
ated: bleeding, pocket depth, recession, attachment loss 
and radiological bone loss. The authors concluded that 
both procedures improve peri-implant health, though 
implantoplasty afforded a much better implant progno-
sis. In this context, bone loss with implantoplasty was 
0-0.01 mm, versus 1.44-1.54 mm without implanto-
plasty.
Regenerative surgery
Regenerative surgery is used when the implant is deci-
sive for prosthetic preservation, or when aesthetic con-
siderations are involved (20,28).
Regenerative treatment requires prior decontamina-
tion of the implant surface (20). Most studies use the 
concept of guided bone surgery (29,30), which includes 
the placement of a membrane after grafting. Many bone 
substitutes are available, though very few randomized 
trials have compared them in the context of the treat-
ment of peri-implantitis. In the studies published by 
Schwarz (28-30), comparisons were made of Bio Oss® 
and Ostim® with a collagen membrane, and involving 
follow-up controls after 6 months and 2 and 4 years. A 
total of 22 patients were included, with the evaluation 
of clinical parameters and radiological bone loss. After 
6 months, both types of material were seen to perform 
equally well, though after 2 and 4 years, Bio Oss® af-
forded greater benefits. 
In relation to the microbial flora associated with the eti-
ology of peri-implantitis, many studies involving DNA 
Author Diagnosis of peri-implantitis No. I 
Types of 
treatment 
compared 
Follow-up 
(months) Study parameters Conclusions 
Romeo et 
al. 2004 
(26) 
-suppuration or 
bleeding
-pocket > 4 mm 
-no mobility 
-horizontal 
radiotransparency 
35 
-resection 
surgery + 
implantoplas
ty
-resection 
surgery
36
-bleeding
-probing 
-pseudopockets 
-recession
Both treatments 
improved the clinical 
parameters, but 
resection surgery plus 
implantoplasty proved 
better
Romeo et 
al. 2007 
(27) 
-suppuration or 
bleeding
-pocket > 4 mm 
-no mobility 
-horizontal 
radiotransparency 
35 
-resection 
surgery + 
implantoplas
ty
-resection 
surgery
36 -mesial and distal implant bone loss 
Resection surgery 
plus implantoplasty 
resulted in lesser bone 
loss 
Schwarz et 
al. 2006 
(28) 
-pocket depth > 6 
mm 
-bone loss > 3 mm  
-no mobility 
-no acute 
periodontitis  
-presence of 
keratinized
mucosa 
22 
-hydroxy-
apatite
nanocrystals 
-Bio Oss® 
plus
membrane 
6
-plaque 
-bleeding
-probing 
-gingival recession 
-attachment loss 
Both treatments 
offered same results 
after 6 months 
Schwarz et 
al. 2008 
(29) 
-pocket depth > 6 
mm 
-bone loss > 3 mm  
-no mobility 
-no acute 
periodontitis  
-presence of 
keratinized
mucosa 
22 
-hydroxy-
apatite
nanocrystals 
-Bio Oss® 
plus
membrane 
24
-plaque 
-bleeding
-probing 
-gingival recession 
-attachment loss 
Bio Oss® plus 
membrane offers 
better results after 2 
years 
Schwarz et 
al. 2009 
(30) 
-pocket depth > 6 
mm 
-bone loss > 3 mm  
-no mobility 
-no acute 
periodontitis  
-presence of 
keratinized
mucosa 
22 
-hydroxy-
apatite
nanocrystals 
-Bio Oss® 
plus
membrane 
48
-plaque 
-bleeding
-probing 
-gingival recession 
-attachment loss 
Bio Oss® offers 
better results after 48 
months
Table 3. Surgical treatment of peri-implantitis.
No. I (number of implants)
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identification techniques have shown the main isolated 
organisms to be Aggregatibacter Actinomycetemcomi-
tans, Prevotella intermedia, Prevotella nigrescens, 
Porphyromonas gingivalis, Treponema denticola, Tan-
nerella forsythia, and Fusobacterium species (3, 10-12, 
16,18).
Following review of the literature, the authors reached 
no consensus in relation to the diagnosis of peri-implan-
titis in terms of bone loss or pocket depth, and likewise 
no criteria were established for assessing the success of 
treatment of peri-implant disease of for defining con-
crete therapeutic protocols.
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